The United States is a top priority for Bioiberica, said the company in a press release, particularly for its three key branded ingredients: Collavant n2 for joint health, Mobilee for muscle and joint support and Dermial for skin and beauty.
“The US plays a pivotal role in our growth strategy, offering unparalleled opportunities to advance innovation and meet rising consumer demand for science-backed health solutions,” said Joan Bassa, director of human health at Bioiberica. “However, succeeding in this dynamic market requires more than a presence—it demands solid collaboration.
“Our union with Stauber goes beyond a distribution agreement—it’s a bold commitment to connect with and empower American supplement manufacturers and advance the field of nutraceutical science through the power of true partnership.”
The ingredients are supported by a scientific portfolio that includes clinical studies and in vitro data, according to the release.
Collavant n2, an undenatured type II collagen ingredient, is recommended with a daily dose of 40 mg. Mobilee, an hyaluronic acid matrix ingredient, is recommended at 80 mg per day. Dermial is recommended at 60 mg per day.
“The unique Bioiberica products enhance our portfolio, particularly in beauty, joint and muscle wellness,” said Shirley Rozeboom, vice president of health & nutrition at Stauber. “We are honored to represent these science-driven ingredients for health and longevity. We look forward to meeting the diverse needs of our customers and industry markets.”